SLFN12 and lung carcinoma: However, even in the absence of a specific drug to target tumors on the basis of their SLFN12 levels, the ability to separate lung cancer patients into high versus low SLFN12 expression may help in predicting the prognosis and subsequent aggressiveness of the chemotherapy.